Northern Star Partners stands at the forefront of venture capital excellence, identifying and accelerating transformative technology companies across semiconductors, displays, and biotechnology sectors. We don't just invest—we build enduring partnerships that reshape industries.
Founded with a vision to bridge the gap between breakthrough Asian innovation and global markets, Northern Star Partners has rapidly established itself as a premier venture capital firm with unparalleled sector expertise and institutional-grade investment processes.
Our strategic vision centers on identifying and nurturing technology companies that possess the potential to fundamentally transform their respective industries. We believe that the convergence of advanced semiconductors, next-generation displays, and revolutionary biotechnology represents the most significant opportunity for value creation in the modern economy.
This focused approach allows us to develop deep expertise in market dynamics, technological trends, and competitive landscapes that generalist investors simply cannot match. Our sector specialization enables us to provide strategic guidance that goes far beyond capital, positioning our portfolio companies for sustained competitive advantage and market leadership.
Our investment methodology is built on rigorous due diligence processes that evaluate not only financial metrics but also technological differentiation, market timing, competitive positioning, and management team capabilities. We employ proprietary analytical frameworks developed specifically for our target sectors, leveraging both quantitative models and qualitative assessments.
Each investment decision undergoes comprehensive technical review by our team of industry experts, ensuring that we understand both the immediate potential and long-term implications of the technologies we support. This methodical approach has resulted in a portfolio with significantly above-market performance metrics and a 17.1% successful exit rate.
Our extensive network spans across major innovation hubs in Asia, North America, and Europe, providing our portfolio companies with access to strategic partnerships, customer relationships, and expansion opportunities that would otherwise be unavailable to emerging companies. We maintain active relationships with over 200 strategic partners across our target sectors.
Through our carefully cultivated relationships with industry leaders, academic institutions, research organizations, and strategic partners, we create value beyond traditional venture capital support, acting as a catalyst for growth and market expansion for every company in our portfolio. Our hands-on approach has accelerated time-to-market by an average of 18 months across our portfolio.
We invest at the intersection of technological innovation and market opportunity, focusing on companies that possess the potential to create new markets or fundamentally transform existing ones through breakthrough technologies and superior execution.
The semiconductor industry is experiencing unprecedented transformation driven by artificial intelligence, 5G infrastructure, and Internet of Things applications. We invest in companies developing next-generation chip architectures, advanced packaging technologies, and specialized processors that will power the digital economy of tomorrow.
Our portfolio companies in this sector are addressing critical challenges in power efficiency, processing capabilities, and manufacturing innovation, positioning them at the forefront of technological advancement with proprietary solutions that command premium valuations.
The future of human-computer interaction lies in advanced display technologies that seamlessly integrate into our daily lives. From flexible OLED screens to augmented reality interfaces, we invest in companies that are reimagining how digital information is presented and consumed across industries.
Our investments span automotive displays, wearable technologies, and immersive computing platforms that are creating entirely new user experiences and market categories. These companies are positioned to capture significant value as display technology becomes increasingly central to product differentiation.
Biotechnology represents one of the most significant opportunities for addressing global health challenges while creating substantial economic value. We focus on companies developing innovative therapeutics, diagnostic technologies, and precision medicine platforms that leverage cutting-edge scientific advances.
Our biotech investments leverage technologies including gene therapy, immunotherapy, and AI-driven drug discovery to accelerate the development of breakthrough treatments and diagnostic solutions. These companies benefit from our deep understanding of regulatory pathways and clinical development processes.
Our leadership team combines decades of investment experience with deep operational expertise across our target sectors. Each team member has a proven track record of identifying, investing in, and building market-leading technology companies with institutional-grade investment processes.
Seejun brings exceptional expertise in semiconductor and technology investments across Asia-Pacific markets. As founding partner, he has led Northern Star Partners' evolution from startup to industry leader, establishing our reputation for sector expertise and operational excellence. Previously Partner at Korea's leading venture capital firm, managing investments exceeding $500M with multiple successful exits including three IPOs valued over $1B combined.
His operational background at Samsung Electronics provides invaluable industry insight and strategic perspective, having managed strategic partnerships and business development for the company's semiconductor division. Seejun serves on six portfolio company boards and is a frequent speaker at major industry conferences including SEMICON Korea and Asian Venture Capital Journal Annual Conference.
Jiun leads our biotechnology investment practice with unparalleled expertise in healthcare innovation and life sciences. His scientific background combined with investment acumen has resulted in exceptional returns across our biotech portfolio, with investments achieving three successful IPOs and two strategic acquisitions totaling over $1B in value creation.
Former Principal at Mirae Asset Venture Investment, Jiun has deep experience in Asian healthcare markets and regulatory environments. His scientific background includes research positions at leading pharmaceutical companies and extensive work in clinical development processes. PhD in Biochemistry from Yonsei University with expertise in drug discovery and regulatory affairs.
Minyoung oversees our display technology investments with exceptional insight into consumer electronics and emerging display applications. Her technical expertise and market knowledge have positioned our portfolio at the forefront of display innovation, with companies developing breakthrough technologies in OLED, flexible displays, and next-generation automotive display systems.
Previously held senior positions at LG Display Corporation, where she led strategic investments and partnerships in emerging display technologies including OLED, flexible displays, and automotive display solutions. Her corporate development experience provides unique perspective on technology commercialization and global market dynamics. MS in Materials Science from Seoul National University.
Seokcheol leads our portfolio support and operational excellence initiatives, providing critical guidance to companies as they scale operations and expand internationally. His hands-on approach has accelerated growth across our entire portfolio, with measurable improvements in operational efficiency and market reach resulting in an average 35% reduction in time-to-market for portfolio companies.
Experienced technology executive with proven track record of successful international expansion and operational scaling across Asian markets. Has led business development initiatives resulting in over $200M in strategic partnerships and market expansion opportunities for high-growth technology companies. Fluent in Korean, English, Mandarin Chinese, and Japanese.
Our disciplined investment approach and sector expertise have generated strong returns across market cycles, with consistent outperformance relative to comparable Asian venture capital funds and global sector-focused peers.
Our portfolio represents a carefully curated collection of industry-leading companies that are defining the future of technology across our target sectors, with a combined enterprise value exceeding $2.5 billion.
Revolutionary immunotherapy company that developed breakthrough T-cell engineering technologies for next-generation cancer treatments. Successfully completed IPO on KOSDAQ in May 2025, representing one of the largest biotech public offerings in Korean market history with strong institutional backing.
Leading developer of advanced SSD controllers and NAND flash memory solutions serving major technology companies worldwide. Completed highly successful IPO in 2023, establishing itself as a key player in the memory semiconductor ecosystem with proprietary controller technologies.
Innovative aerospace company developing small satellite launch vehicles and space technology solutions for commercial and government clients across Asia. IPO in 2024 established leadership in Asian commercial space sector with proven launch capabilities.
Biotechnology company focused on developing novel drug delivery systems and therapeutic solutions for complex medical conditions. Currently advancing multiple candidates through clinical trials with strong preliminary results and clear regulatory pathway.
Leading provider of electric vehicle charging management software, serving charging networks and fleet operators across North America and Asia. Experiencing rapid growth as EV adoption accelerates globally with major automotive partnerships.
Gaming and entertainment platform connecting millions of users across Asia through innovative social gaming experiences and interactive content. Strong monetization metrics and user engagement with clear path to market leadership.
We welcome conversations with exceptional entrepreneurs, institutional investors, and strategic partners who share our vision for building transformative technology companies that reshape global markets.
405 Hangang-daero, Yongsan District
Seoul 04509, South Korea
Phone: +82 (0)26 914 9377
Fax: +82 (0)26 951 1698
Building breakthrough technology in semiconductors, displays, or biotechnology? We provide strategic expertise, industry connections, and operational support to accelerate your path to market leadership. Please include your executive summary, financial projections, and competitive analysis.
Institutional investors seeking exposure to Asia's most promising technology sectors can access our comprehensive investor materials, performance data, and due diligence documentation through our secure LP portal.